G. E. Brkich, N. V. Pyatigorskaya, N. B. Demina, O. A. Zyryanov, I. I. Krasnyuk
G. E. Brkich*, N. V. Pyatigorskaya, N. B. Demina, O. A. Zyryanov, I. I. Krasnyuk
Sechenov First Moscow State Medical University, Trubetskaya Street, 8, Moscow, 119991, Russian Federation.
Volume - 12,
Issue - 12,
Year - 2019
Different derivatives of 4-hydroxy-3-methoxy benzoic acid were synthesized and evaluated for their antioxidant, a-amylase inhibition and urease inhibition ability. Antioxidant evaluation was performed by DPPH radical scavenging assay and the results revealed that compounds 8, 10 and 13 as most active antioxidant agent with IC50 values of 43.09µg/ml, 44.59µg/ml and 43.43µg/ml respectively. a-Amylase inhibition study was performed using diastase by colorimetric method. Compound 9 showed maximum inhibition with IC50 value of 33.26 µg/ml. Compound 4 was found to possess maximum urease inhibition ability with IC50 value of 35.82µg/ml. Molecular docking study was performed using autodock software.
Cite this article:
G. E. Brkich, N. V. Pyatigorskaya, N. B. Demina, O. A. Zyryanov, I. I. Krasnyuk. Scientific and Methodical approach to developing the formulation of an Innovative Medicinal Product based on a derivative of 3,7-diazabicyclo [3.3.1]nonane (hydrindane). Research J. Pharm. and Tech. 2019; 12(12): 5752-5756. doi: 10.5958/0974-360X.2019.00996.X